mutation spectra (90.85, 1.0E-4); new approaches (90.85, 1.0E-4); understanding p53 gene tumor (90.85, 1.0E-4); compound k (79.44, 1.0E-4); multiple pathway (79.44, 1.0E-4). This evidence concerns the gene TP53 and neoplasm.